Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow-to-Debt Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited cash flow-to-debt ratio. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2023, meaning its operating cash flow of €2.10 Billion could theoretically repay 0% of its total liabilities (€38.23 Billion) in one year. Check GU5 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Cash flow-to-debt ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. Historical debt coverage capacity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 13 annual periods. Check how aggressively does Guangzhou Baiyunshan Pharmaceutical Hold reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow-to-Debt Ratio by Year (2013–2025)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For the full cash flow conversion analysis, see GU5 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | €-232.46 Million | €44.43 Billion | ▼ -106.7% |
| 2024 | 0.08x | €3.44 Billion | €43.91 Billion | ▼ -19.9% |
| 2023 | 0.10x | €4.10 Billion | €41.91 Billion | ▼ -42.6% |
| 2022 | 0.17x | €7.00 Billion | €41.03 Billion | ▲ +4.6% |
| 2021 | 0.16x | €5.67 Billion | €34.79 Billion | ▲ +779.3% |
| 2020 | 0.02x | €585.19 Million | €31.55 Billion | ▼ -88.6% |
| 2019 | 0.16x | €5.02 Billion | €30.90 Billion | ▼ -11.7% |
| 2018 | 0.18x | €5.22 Billion | €28.34 Billion | ▼ -9.1% |
| 2017 | 0.20x | €1.83 Billion | €9.05 Billion | ▼ -34.4% |
| 2016 | 0.31x | €2.54 Billion | €8.24 Billion | ▲ +14.2% |
| 2015 | 0.27x | €1.94 Billion | €7.19 Billion | ▼ -1.9% |
| 2014 | 0.28x | €1.75 Billion | €6.34 Billion | ▲ +7.8% |
| 2013 | 0.26x | €1.34 Billion | €5.23 Billion | — |